Related Experiment Video
Updated: May 24, 2026
06:05
The Participant-Reported Implementation Update and Score (PRIUS): A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
Application, review, and reporting process for Waivers for State Innovation. Final rule
Federal Register
|March 3, 2012
Summary
This rule establishes procedures for states seeking a Section 1332 waiver under the Affordable Care Act. It ensures public input during application development and federal review for state innovation waivers.
Area of Science:
- Health Policy
- Healthcare Regulation
- Public Administration
Background:
- Section 1332 of the Patient Protection and the Affordable Care Act allows states to apply for waivers for innovative healthcare initiatives.
- Existing frameworks may lack detailed procedural guidance for the submission and review of these waiver applications.
- Ensuring public participation is crucial for the legitimacy and effectiveness of state-driven healthcare reforms.
Purpose of the Study:
- To establish a procedural framework for the submission and review of initial applications for Section 1332 Waivers for State Innovation.
- To outline processes that guarantee opportunities for public input in both the development and federal review stages of state applications.
- To provide clarity and standardization for states seeking to implement innovative healthcare programs under federal guidelines.
Main Methods:
- This document is a final rule, outlining procedural requirements.
- It details the steps for states submitting initial waiver applications.
- It specifies mechanisms for incorporating public comment throughout the application and review process.
Main Results:
- A clear procedural framework for Section 1332 waiver applications has been established.
- Processes for ensuring public input are integrated into the application submission and federal review.
- The rule provides a standardized pathway for states to pursue innovative healthcare reforms.
Conclusions:
- The final rule provides a comprehensive procedural roadmap for states seeking Section 1332 waivers.
- Enhanced public engagement is mandated, fostering transparency in state innovation initiatives.
- This framework aims to facilitate the approval and implementation of state-led healthcare innovations under the Affordable Care Act.
More Related Videos
Related Concept Videos
01:13Bioequivalence studies: Biowaivers
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:26FDA Approved Drugs: Changes to Approved Drugs
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
01:30Health Information Technology and Healthcare Information System
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
01:28Global Regulatory Systems
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...